330128
Citywide Homicide Review to Track Age Trends in Violence
Methods. The group reviewed each homicide in Pittsburgh, PA over 3 years (2012-2014) and identified cases involving gang/peer competition. Ages of victims in this category were compared to the ages of victims whose violent death did not involve retaliation, disrespect, or neighborhood conflict. Mean age and 95% confidence intervals (using bootstrap procedures) were computed for each group in each year.
Results/Outcomes. There were 42 homicides in 2012, 47 in 2013, and 69 in 2014. Nearly 90% involved firearms and African-American victims. Peer/gang victims overall were younger (26.9 [24.7-29.3] vs. 34.2 [30.8-37.9], p < .001). The ages of peer/gang victims increased over the 3 years (23.2, 28.2, 29.2), though differences did not achieve significance. Other deaths did not show a consistent trend in age (32.4, 35.9, 34.2). The proportion of deaths involving gang/peer conflict was 33% in 2012, 60% in 2013, and 50% in 2014.
Conclusions. The increase in homicides in Pittsburgh, PA over 2012-14 was associated with a greater proportion of gang/peer conflicts. These homicide victims are younger, but gang/peer violence may now be increasing to include a wider age range.
Learning Areas:
Diversity and culturePlanning of health education strategies, interventions, and programs
Public health or related laws, regulations, standards, or guidelines
Social and behavioral sciences
Learning Objectives:
Assess value of citywide homicide review model for tracking trends in violence.
Evaluate relationship between context of homicide (gang/peer-based vs. other) and age of victims
Keyword(s): Youth Violence, Mortality
Qualified on the content I am responsible for because: I oversee the Pittsburgh homicide review group, arrange for participants to a trend, and supervise staff involved in data retrieval and preparation of reports. I co-direct this effort with Steven M. Albert, PI of the project.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.